Long COVID: How Researchers Are Zeroing in on the Self-Targeted Immune Attacks that May Lurk Behind It

Indonesia Berita Berita

Long COVID: How Researchers Are Zeroing in on the Self-Targeted Immune Attacks that May Lurk Behind It
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 snopes
  • ⏱ Reading Time:
  • 58 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 27%
  • Publisher: 63%

For almost three years, scientists have raced to understand the immune responses in patients who develop severe COVID-19. — The Conversation

. We now know that in patients with severe COVID-19, many of the developing antibodies responsible for neutralizing the viral threat are simultaneously targeting their own organs and tissues. We also show that self-directed antibodies can persist for months or even years in those suffering from long COVID-19.

As researchers like us continue to study COVID-19, our understanding of the link between antiviral immunity and chronic autoimmune disease is rapidly evolving. https://www.youtube.com/embed/2ECsro9t_c0?wmode=transparent&start=0 More than three years into the pandemic, there is not one unifying explanation for why people experience the symptoms known as long COVID-19.

To prevent self-destruction, the immune system relies on an intricate series of fail-safes that are collectively termedto identify and eliminate potentially traitorous immune cells. One of the most important steps in this process occurs as the immune system builds up its arsenal against a potential threat.

When your immune system first encounters a pathogen or even a perceived threat – such as a vaccine that resembles a virus – it rapidly recruits “B” cells that have the potential to become antibody-producers. Then, any of these “naive” B cell recruits – naive being a technical term used in immunology – that demonstrate an ability to competently attack the invader are put intoHere, the cells are trained to better recognize and combat the threat.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

snopes /  🏆 228. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Populous Chinese cities including Shenzhen ramp up COVID curbsPopulous Chinese cities including Shenzhen ramp up COVID curbsSeveral big Chinese cities escalated COVID-19 restrictions on Tuesday, with Shenzhen closing more businesses and Dalian locking down millions, renewing economic uncertainty and delaying the start of the school year for some.
Baca lebih lajut »

Josh Shapiro breaks with Democrats on COVID policies in Pennsylvania governor’s raceJosh Shapiro breaks with Democrats on COVID policies in Pennsylvania governor’s raceAs attorney general, Josh Shapiro went to court repeatedly to defend Pennsylvania Gov. Tom Wolf’s administration against legal challenges to his pandemic-era mandates and shutdowns.
Baca lebih lajut »

When We Rose to Fight COVID, We Were Deliberately Turned Against Each OtherWhen We Rose to Fight COVID, We Were Deliberately Turned Against Each OtherThere was a time when we came together to fight COVID, but that energy threatened the status quo more than the virus.
Baca lebih lajut »

How to check if your at-home COVID test has expiredHow to check if your at-home COVID test has expiredYes, COVID tests expire, but yours may still have some shelf life. Make sure your test is still good by using the FDA database. Here's how.
Baca lebih lajut »

Column: GOP ratchets up the hypocrisy in opposing Biden's student debt planColumn: GOP ratchets up the hypocrisy in opposing Biden's student debt plan'It’s well past time for the critics of student debt relief to get honest about their real purpose. It’s to protect wealthier Americans who fear their income taxes will have to rise to pay for that relief,' writes hiltzikm.
Baca lebih lajut »

Scientists question Moderna invention claim in COVID-19 vaccine disputeThe makers of the two most widely used COVID19 vaccines in the United States are now in a patent fight over their shots.
Baca lebih lajut »



Render Time: 2025-03-13 02:43:27